Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration von Drilon, Alexander, Clark, Jeffrey W., Weiss, Jared, Ou, Sai-Hong Ignatius, Camidge, D. Ross, Solomon, Benjamin J., Otterson, Gregory A., Villaruz, Liza C., Riely, Gregory J., Heist, Rebecca S., Awad, Mark M., Shapiro, Geoffrey I., Satouchi, Miyako, Hida, Toyoaki, Hayashi, Hidetoshi, Murphy, Danielle A., Wang, Sherry C., Li, Sherry, Usari, Tiziana, Wilner, Keith D., Paik, Paul K.

Volltext

Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study von Goss, Glenwood, Dr Prof, Tsai, Chun-Ming, Prof, Shepherd, Frances A, Prof, Bazhenova, Lyudmila, Prof, Lee, Jong Seok, MD, Chang, Gee-Chen, MD, Crino, Lucio, MD, Satouchi, Miyako, MD, Chu, Quincy, MD, Hida, Toyoaki, MD, Han, Ji-Youn, Prof, Juan, Oscar, MD, Dunphy, Frank, Prof, Nishio, Makoto, MD, Kang, Jin-Hyoung, MD, Majem, Margarita, MD, Mann, Helen, MSc, Cantarini, Mireille, MD, Ghiorghiu, Serban, MD, Mitsudomi, Tetsuya, Prof

Volltext

Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial von Hida, Toyoaki, MD, Nokihara, Hiroshi, MD, Kondo, Masashi, MD, Kim, Young Hak, MD, Azuma, Koichi, MD, Seto, Takashi, MD, Takiguchi, Yuichi, Prof, Nishio, Makoto, MD, Yoshioka, Hiroshige, MD, Imamura, Fumio, MD, Hotta, Katsuyuki, Prof, Watanabe, Satoshi, MD, Goto, Koichi, MD, Satouchi, Miyako, MD, Kozuki, Toshiyuki, MD, Shukuya, Takehito, MD, Nakagawa, Kazuhiko, Prof, Mitsudomi, Tetsuya, Prof, Yamamoto, Nobuyuki, Prof, Asakawa, Takashi, PhD, Asabe, Ryoichi, MS, Tanaka, Tomohiro, MS, Tamura, Tomohide, Dr

Volltext

ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer von Shaw, Alice T, Solomon, Benjamin J, Besse, Benjamin, Bauer, Todd M, Lin, Chia-Chi, Soo, Ross A, Riely, Gregory J, Ou, Sai-Hong Ignatius, Clancy, Jill S, Li, Sherry, Abbattista, Antonello, Thurm, Holger, Satouchi, Miyako, Camidge, D Ross, Kao, Steven, Chiari, Rita, Gadgeel, Shirish M, Felip, Enriqueta, Martini, Jean-François

Volltext

Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study von Katsuya, Yuki, Horinouchi, Hidehito, Seto, Takashi, Umemura, Shigeki, Hosomi, Yukio, Satouchi, Miyako, Nishio, Makoto, Kozuki, Toshiyuki, Hida, Toyoaki, Sukigara, Tamie, Nakamura, Kenichi, Kuchiba, Aya, Ohe, Yuichiro

Volltext

Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer von Nakagawa, Kazuhiko, Hida, Toyoaki, Nokihara, Hiroshi, Morise, Masahiro, Azuma, Koichi, Kim, Young Hak, Seto, Takashi, Takiguchi, Yuichi, Nishio, Makoto, Yoshioka, Hiroshige, Kumagai, Toru, Hotta, Katsuyuki, Watanabe, Satoshi, Goto, Koichi, Satouchi, Miyako, Kozuki, Toshiyuki, Koyama, Ryo, Mitsudomi, Tetsuya, Yamamoto, Nobuyuki, Asakawa, Takashi, Hayashi, Morihiko, Hasegawa, Wakako, Tamura, Tomohide

Volltext

Vandetanib in patients with previously treated RET -rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial von Yoh, Kiyotaka, Dr, Seto, Takashi, MD, Satouchi, Miyako, MD, Nishio, Makoto, MD, Yamamoto, Noboru, MD, Murakami, Haruyasu, MD, Nogami, Naoyuki, MD, Matsumoto, Shingo, MD, Kohno, Takashi, PhD, Tsuta, Koji, Prof, Tsuchihara, Katsuya, MD, Ishii, Genichiro, MD, Nomura, Shogo, MSc, Sato, Akihiro, MD, Ohtsu, Atsushi, MD, Ohe, Yuichiro, MD, Goto, Koichi, MD

Volltext

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, rando... von Mitsudomi, Tetsuya, Dr, Morita, Satoshi, Prof, Yatabe, Yasushi, MD, Negoro, Shunichi, MD, Okamoto, Isamu, MD, Tsurutani, Junji, MD, Seto, Takashi, MD, Satouchi, Miyako, MD, Tada, Hirohito, MD, Hirashima, Tomonori, MD, Asami, Kazuhiro, MD, Katakami, Nobuyuki, MD, Takada, Minoru, Prof, Yoshioka, Hiroshige, MD, Shibata, Kazuhiko, MD, Kudoh, Shinzoh, MD, Shimizu, Eiji, Prof, Saito, Hiroshi, MD, Toyooka, Shinichi, MD, Nakagawa, Kazuhiko, Prof, Fukuoka, Masahiro, Prof

Volltext

Multiplex gene‐panel testing for lung cancer patients von Yatabe, Yasushi, Sunami, Kuniko, Goto, Koichi, Nishio, Kazuto, Aragane, Naoko, Ikeda, Sadakatsu, Inoue, Akira, Kinoshita, Ichiro, Kimura, Hideharu, Sakamoto, Tomohiro, Satouchi, Miyako, Shimizu, Junichi, Tsuta, Koji, Toyooka, Shinichi, Nishino, Kazumi, Hatanaka, Yutaka, Matsumoto, Shingo, Mikubo, Masashi, Yokose, Tomoyuki, Dosaka‐Akita, Hirotoshi

Volltext

Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG060... von Goto, Koichi, Dr, Ohe, Yuichiro, MD, Shibata, Taro, MSc, Seto, Takashi, MD, Takahashi, Toshiaki, MD, Nakagawa, Kazuhiko, Prof, Tanaka, Hiroshi, MD, Takeda, Koji, MD, Nishio, Makoto, MD, Mori, Kiyoshi, MD, Satouchi, Miyako, MD, Hida, Toyoaki, MD, Yoshimura, Naruo, MD, Kozuki, Toshiyuki, MD, Imamura, Fumio, MD, Kiura, Katsuyuki, Prof, Okamoto, Hiroaki, MD, Sawa, Toshiyuki, MD, Tamura, Tomohide, MD

Volltext

Combined Analysis of V20, VS5, Pulmonary Fibrosis Score on Baseline Computed Tomography, and Patient Age Improves Prediction of Severe Radiation Pneumonitis After Concurrent Chemor... von Tsujino, Kayoko, Hashimoto, Tomohisa, Shimada, Temiko, Yoden, Eisaku, Fujii, Osamu, Ota, Yosuke, Satouchi, Miyako, Negoro, Shunichi, Adachi, Shuji, Soejima, Toshinori

Volltext

Severe Skin Toxicity Caused by Sequential Anti-PD-1 Antibody and Alectinib in Non-small-cell Lung Cancer: A Report of Two Cases and a Literature Review von Nishiyama, Akihiro, Hattori, Yoshihiro, Takeuchi, Shinji, Tanimoto, Azusa, Satouchi, Miyako, Murayama, Toshinori, Yano, Seiji

Volltext

Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: West Japan... von YAMAMOTO, Nobuyuki, NAKAGAWA, Kazuhiko, SAWA, Toshiyuki, YOKOTA, Soichiro, SETO, Takashi, IMAMURA, Fumio, SAKA, Hideo, IWAMOTO, Yasuo, SEMBA, Hiroshi, CHIBA, Yasutaka, UEJIMA, Hisao, FUKUOKA, Masahiro, NISHIMURA, Yasumasa, TSUJINO, Kayoko, SATOUCHI, Miyako, KUDO, Shinzoh, HIDA, Toyoaki, KAWAHARA, Masaaki, TAKEDA, Koji, KATAKAMI, Nobuyuki

Volltext

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA von John, Thomas, Sakai, Hiroshi, Ikeda, Satoshi, Cheng, Ying, Kasahara, Kazuo, Sato, Yuki, Nakahara, Yoshiro, Takeda, Masayuki, Kaneda, Hiroyasu, Zhang, Helong, Maemondo, Makoto, Minato, Koichi, Hisada, Takeshi, Misumi, Yuki, Satouchi, Miyako, Hotta, Katsuyuki, Li, Ang, Oukessou, Abderrahim, Lu, Shun

Volltext

Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: A Japanese national registry study (J-CROS-LUNG) von Kubo, Nobuteru, Suefuji, Hiroaki, Nakajima, Mio, Tokumaru, Sunao, Okano, Naoko, Yoshida, Daisaku, Suzuki, Osamu, Ishikawa, Hitoshi, Satouchi, Miyako, Nakayama, Haruhiko, Shioyama, Yoshiyuki

Volltext

Immune-related Colitis Induced by the Long-term Use of Nivolumab in a Patient with Non-small Cell Lung Cancer von Yasuda, Yuichiro, Urata, Yoshiko, Tohnai, Rie, Ito, Shoichi, Kawa, Yoshitaka, Kono, Yuko, Hattori, Yoshihiro, Tsuda, Masahiro, Sakuma, Toshiko, Negoro, Shunichi, Satouchi, Miyako

Volltext

KEYNOTE‐025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1–positive advanced non–small‐cell lung cancer von Nishio, Makoto, Takahashi, Toshiaki, Yoshioka, Hiroshige, Nakagawa, Kazuhiko, Fukuhara, Tatsuro, Yamada, Kazuhiko, Ichiki, Masao, Tanaka, Hiroshi, Seto, Takashi, Sakai, Hiroshi, Kasahara, Kazuo, Satouchi, Miyako, Han, Shi Rong, Noguchi, Kazuo, Shimamoto, Takashi, Kato, Terufumi

Volltext

Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study von Sueoka‐Aragane, Naoko, Katakami, Nobuyuki, Satouchi, Miyako, Yokota, Soichiro, Aoe, Keisuke, Iwanaga, Kentaro, Otsuka, Kojiro, Morita, Satoshi, Kimura, Shinya, Negoro, Shunichi

Volltext

Glucose metabolism‐targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor‐induced drug‐tolerant persisters von Kunimasa, Kei, Nagano, Tatsuya, Shimono, Yohei, Dokuni, Ryota, Kiriu, Tatsunori, Tokunaga, Shuntaro, Tamura, Daisuke, Yamamoto, Masatsugu, Tachihara, Motoko, Kobayashi, Kazuyuki, Satouchi, Miyako, Nishimura, Yoshihiro

Volltext

Phase III Trial Comparing Oral S-1 Plus Carboplatin With Paclitaxel Plus Carboplatin in Chemotherapy-Naïve Patients With Advanced Non–Small-Cell Lung Cancer: Results of a West Japa... von OKAMOTO, Isamu, YOSHIOKA, Hiroshige, KUDOH, Shinzoh, SATOUCHI, Miyako, IKEDA, Norihiko, IWAMOTO, Yasuo, SAWA, Toshiyuki, MIYAZAKI, Masaki, TAMURA, Kenji, KURATA, Takayasu, FUKUOKA, Masahiro, NAKAGAWA, Kazuhiko, MORITA, Satoshi, ANDO, Masahiko, TAKEDA, Koji, SETO, Takashi, YAMAMOTO, Nobuyuki, SAKA, Hideo, ASAMI, Kazuhiro, HIRASHIMA, Tomonori

Volltext